SCHEMBL4239133

SCHEMBL4239133

O=S(=O)(O)C(CN1CCN(CCO)CC1)N1CCN(CCO)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TP53 P04637 1/20 0.33
TERT O14746 1/20 0.32
HSD11B1 P28845 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5062392 0.87 CHRM2 (0.40) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL2490415 0.86 CHRM2 (0.40) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL3911963 0.84 CHRM2 (0.39) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL126114 0.84 CHRM2 (0.42) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL129496 0.81 CHRM2 (0.40) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL3414469 0.80 CHRM2 (0.39) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL1919485 0.79 KMT2A (0.47) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL22345800 0.79 CHRM2 (0.46) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL4259360 0.78 HTT (0.50) KMT2ALMNAHTTCHRM2CHRM1
SCHEMBL64211 0.76 CHRM2 (0.47) KMT2ALMNAHTTCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009139939-A2 HYBRID NANOPARTICLES AS ANTI-CANCER THERAPEUTIC AGENTS AND DUAL THERAPEUTIC/IMAGING CONTRAST AGENTS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2009-11-19 WO disclosed
US-6656711-B2 Concentrating epothilones in culture from Sorangium strains obtained by mutagenesis; antitumor agents NOVARTIS AG (CH) 2003-12-02 US disclosed